Mattia Galli/LinkedIn
Sep 8, 2025, 14:22
GLP-1 Receptor Agonists and Cardiovascular Benefits․ Role of Clinical Features
Mattia Galli, Assistant Professor at Sapienza Università di Roma, Associate Editor of European Heart Journal, shared a post on X:
”Clinical features modifying the cardiovascular benefits of GLP-1 receptor agonists. A systematic review and meta-analysis.
Read more here.
Stay updated with Hemostasis Today.
-
Jul 15, 2026, 13:43Katarina Miljević: New Insights into Recombinant tPA and FXI Inhibition at ISTH 2026
-
Jul 15, 2026, 13:31Sandrine Meunier: ISTH 2026 Highlights Consensus on Pediatric Hemostatic Assessment
-
Jul 15, 2026, 13:20Mauricio Bordonaba: Reflecting on ISTH 2026 and Our Commitment to a Truly Free Hemophilia Life
-
Jul 15, 2026, 07:15Sandrine Horman: Back From an Inspiring Week at ISTH 2026
-
Jul 15, 2026, 06:55Christopher Devany: Great to Be Here in Paris for the ISTH 2026
-
Jul 15, 2026, 06:45Viviana Di Fabio: The Synergy Between Hematology and Hemostasis Starts with Platelets
-
Jul 15, 2026, 06:35Wolfgang Miesbach: Paediatric Phase 3 BASIS KIDS Data for Marstacimab at ISTH 2026
-
Jul 15, 2026, 06:06Marija Tashkovska: Advancing Knowledge and Clinical Practice Through ISTH 2026
-
Jul 15, 2026, 05:55Hong Chow: Where Science Meets Art at ISTH 2026